Metabolon Launches Targeted Panels to Help Identify Gut Health Biomarkers
The new panels are designed to target dozens of microbially-derived metabolites across multiple pathways to advance pre-clinical efforts.
Read MorePosted by Andy Lundin | Apr 4, 2023 | Diabetes & Metabolic Diseases |
The new panels are designed to target dozens of microbially-derived metabolites across multiple pathways to advance pre-clinical efforts.
Read MorePosted by Chris Wolski | Feb 28, 2023 | Urinalysis & Toxicology |
UTI complications are common for pregnant women and newborns, and is critical to accurately diagnose and treat patients.
Read MorePosted by Andy Lundin | Feb 24, 2023 | Womens Health |
Women who developed mood and anxiety disorders related to pregnancy and childbirth had altered proteins circulating in their bloodstream.
Read MorePosted by Andy Lundin | Feb 23, 2023 | Cardiovascular |
Eko, a digital health company applying AI to address heart and lung disease, has launched the SENSORA Cardiac Disease Detection Platform.
Read MorePosted by Andy Lundin | Feb 6, 2023 | Diagnostic Technologies, Disease States |
A new saliva-based test that can predict the risk of developing different kinds of cancers and other serious diseases is now available.
Read More